Healthcare Anti-Obesity Drugs Market | Page 2
The global anti-obesity drugs market is segmented into product type such as
prescription drugs and over the counter drugs. Among these segments, over the
counter drugs segment is expected to occupy top position in overall anti-obesity
drugs market during the forecast period. Further, easy availability of over-the-
counter drugs in many nations is driving the major factor behind the growth of
over the counter drug segment. Furthermore, major pharmaceutical industries
such as GlaxoSmithKline are engaged in the development, manufacturing and
marketing of OTC anti-obesity drugs. This factor is expected to strengthen the
market of over the counter anti-obesity drugs.
Global anti-obesity drugs market is expected to flourish at a significant CAGR of
40.0% during the forecast period. Moreover, the global anti-obesity drugs market
is predicted to garner noteworthy revenue by the end of 2021. Factors such as
growing population of obese peoples, rising awareness about obesity related
diseases, growing healthcare expenditure are anticipated to be the dynamic factor
behind the growth of anti-obesity drugs market.
North America dominated the overall market of anti-obesity drugs in 2016.
Further, North America is projected to continue its dominance over the forecast
period owing to the high percentage of adults with obesity in the region. As per
the U.S. Department of Health and Human Services, currently, more than one
third of the adult populations are suffering from obesity. Europe anti-obesity
drugs market is projected to showcase substantial growth during the forecast
period. Rapid rate in growth of overweight and obese population (from 50% in
2008 to 51.6% in 2017) in the European region is expected to fuel the growth of
anti-obesity drugs market.
Rise in the Prevalence of Obesity
Increasing number of adults with obesity is anticipated to drive the growth of the
anti-obesity drugs market during the forecast period. Moreover, growing cases of
obesity among children across the globe is expected to substantially raise the
demand for anti-obesity drugs during the forecast period.
Request For Sample
request/2/rep-id-23
Pages:
https://www.researchnester.com/sample-
Increasing Healthcare Awareness
Copyright © Research Nester
www.researchnester.com